Addressing Key Biotherapeutic Challenges With Novel Chromatography Resins

White Paper Mar 10, 2021

Advances in monoclonal antibodies and biotherapeutics are generating a wider range of biomolecules. However, with this molecular diversity, unique separation and purification challenges arise that are often difficult to overcome. Typical impurities include nucleic acids (DNA, RNA), host cell proteins, aggregates and glycosylation and charge variants, as well as potential viral contamination. These impurities can prove problematic to separate but need to be cleared to acceptable levels in accordance with guidelines established by regulatory agencies.

Download this whitepaper to discover hydrophobic interaction chromatography resins that:

Provide unique selectivity towards target molecules
Have excellent resolution, even at lower conductivity conditions
Deliver flow rate independent performance leading to a reduction in processing times

VIEW WHITE PAPER

Related White Papers

Cubis® II Pharma Compliant by Design

White Paper

It is paramount within the pharmaceutical industry that scientists can manage large amounts of data efficiently and safely. The Cubis® II balance series was designed for customizable modularity, meeting the needs of the industry whilst maintaining full compliance.

Accelerating Drug Discovery With an Automated Single-Cell Workflow

White Paper

Single-cell sequencing is quickly becoming a standard tool in biological research due to the scale and depth of insight it provides across diverse cell populations. The pharmaceutical industry is exploiting single-cell approaches to identify novel therapeutic targets and accelerate promising assets through development.

Running Ultra-Large Gold Docking Jobs on Cloud Resources

White Paper

Access this whitepaper to discover a system that performs virtual screening at ultra-high-throughput scale, requires minimal costs and can be run with cloud computing or HPC resources.

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free